Pemetrexed and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David S. Miller, MD
Simmons Cancer Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Usc/norris Comprehensive Cancer Center and Hospital
Los Angeles, California, United States
- Chao Family Comprehensive Cancer Center at University of California Irvine Medical Center
Orange, California, United States
- University of Mississippi Cancer Clinic
Jackson, Mississippi, United States
- Women'S Cancer Center - la Canada
Las Vegas, Nevada, United States
- Metrohealth Cancer Care Center at Metrohealth Medical Center
Cleveland, Ohio, United States
- Oklahoma University Cancer Institute
Oklahoma City, Oklahoma, United States
- Cancer Care Associates - Saint Francis Campus
Tulsa, Oklahoma, United States
- Parkland Memorial Hospital
Dallas, Texas, United States
- Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas
Dallas, Texas, United States
- Lyndon B. Johnson General Hospital
Houston, Texas, United States
- M. D. Anderson Cancer Center at University of Texas
Houston, Texas, United States
- Carilion Gynecologic Oncology Associates
Roanoke, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2008
- Primary completion
- 31 Jul 2014
- Completion
- 31 Jul 2014
- Last update posted
- 9 Jan 2018
- Registered enrollment
- 55
- Registry id
- NCT00691301
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.